PSA Vice President Professor Mark Naunton MPS[/caption]
Dr Louise Schaper at PSA25[/caption]
Why pharmacist accreditation is important
With demand for pharmacists in aged care set to rise, and the removal of the re-accreditation fee, there has never been a better time to broaden your scope of practice through accreditation.
WHO puts ‘temporary pause’ on hydroxychloroquine trial for coronavirus patients
A trial of hydroxychloroquine for COVID-19 treatment has been suspended after researchers found patients receiving the drug were at higher risk of heart problems and death.
Better COVID-19 communication needed, PSA tells Vic govt committee
Insufficient or unhelpful communication from authorities has been the most frustrating aspect of the COVID-19 crisis since restrictions started, according to Victorian pharmacists.
Preparing to vaccinate children under 12 against COVID-19
On 5 December, the Therapeutic Goods Administration (TGA) provisionally approved Pfizer’s COVID-19 vaccine for children over 5 years of age.
Diary of a pharmacist in lockdown
Accredited pharmacist Kay Morey MPS has been in the thick of the COVID-19 crisis. She shares what life has been like during the past 7 months.
Chlorpromazine: from antihistamine to antipsychotic
While chlorpromazine’s use on people with schizophrenia has been overtaken by atypical antipsychotics, it is still used widely.
